MELE, GIUSEPPE
 Distribuzione geografica
Continente #
AS - Asia 385
NA - Nord America 186
EU - Europa 147
SA - Sud America 138
AF - Africa 14
Totale 870
Nazione #
US - Stati Uniti d'America 169
SG - Singapore 163
BR - Brasile 115
CN - Cina 81
IT - Italia 70
VN - Vietnam 70
HK - Hong Kong 29
DE - Germania 19
KR - Corea 13
AR - Argentina 12
FI - Finlandia 11
FR - Francia 9
GB - Regno Unito 9
MX - Messico 8
AT - Austria 7
RU - Federazione Russa 7
BD - Bangladesh 6
EC - Ecuador 6
IN - India 6
UA - Ucraina 5
ZA - Sudafrica 5
CA - Canada 3
CZ - Repubblica Ceca 3
IQ - Iraq 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
PA - Panama 2
PE - Perù 2
PL - Polonia 2
TR - Turchia 2
AO - Angola 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
ES - Italia 1
ET - Etiopia 1
GT - Guatemala 1
ID - Indonesia 1
IE - Irlanda 1
IL - Israele 1
JP - Giappone 1
KE - Kenya 1
MA - Marocco 1
NL - Olanda 1
SE - Svezia 1
SN - Senegal 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 870
Città #
Singapore 59
Florence 38
Hong Kong 29
Boardman 27
Ho Chi Minh City 26
Hefei 23
Beijing 22
Dallas 21
Ashburn 20
Seoul 13
Hanoi 12
Los Angeles 10
Munich 10
São Paulo 9
New York 8
Shanghai 8
Helsinki 7
Milan 7
Vienna 6
Mexico City 5
Porto Alegre 5
Rio de Janeiro 5
Sesto Fiorentino 5
Washington 5
Charlotte 4
Curitiba 4
Da Nang 4
Noto 4
Santa Clara 4
Atlanta 3
Bari 3
Chicago 3
Guayaquil 3
Haiphong 3
Johannesburg 3
Thái Nguyên 3
Turku 3
Aracaju 2
Belo Horizonte 2
Biên Hòa 2
Bologna 2
Brooklyn 2
Bắc Giang 2
Campinas 2
Carney 2
Caxias do Sul 2
Chennai 2
Denver 2
Enfield 2
Fortaleza 2
Juiz de Fora 2
Londrina 2
Quito 2
Raipur 2
Recife 2
Ribeirão Preto 2
Rome 2
San Luis 2
Santo Domingo 2
Secaucus 2
Vĩnh Tường 2
Addis Ababa 1
Ankara 1
Annaba 1
Baghdad 1
Baku 1
Bandar Seri Begawan 1
Barra da Estiva 1
Basmat Tab'un 1
Belford Roxo 1
Betim 1
Bexley 1
Blumenau 1
Bolingbrook 1
Brantford 1
Brasília 1
Bursa 1
Bình Dương 1
Camaçari 1
Campo Erê 1
Campo Grande 1
Can Tho 1
Canoas 1
Capão da Canoa 1
Carapicuíba 1
Catende 1
Changsha 1
Chapecó 1
Cirò Marina 1
Cocos Municipality 1
Colorado 1
Concepción 1
Cumandá 1
Dakar 1
Del Viso 1
Dera Ghazi Khan 1
Dhaka 1
Dubai 1
Dublin 1
Duhok 1
Totale 511
Nome #
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients 90
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials 89
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 80
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials 76
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab-Refractory Multiple Myeloma Patients: A Multicenter Real-World Study 75
Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experience 70
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 65
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials 62
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab‐, Elotuzumab‐, and Carfilzomib‐Based Triplet Regimens: A Multicenter Real‐World Analysis of 635 Patients 60
Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study 59
Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials 56
REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA 51
Lenalidomide maintenance after bortezomib, thalidomide and dexamethasone (VTD) induction and autologous stem cell transplantation: an Italian real-life study of 602 patients 50
Totale 883
Categoria #
all - tutte 5.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.086


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202311 0 0 0 0 0 0 7 0 0 0 4 0
2023/2024122 2 2 22 20 8 15 8 1 1 2 5 36
2024/2025283 2 18 5 10 16 16 10 22 39 36 34 75
2025/2026467 94 54 68 71 142 38 0 0 0 0 0 0
Totale 883